These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6622297)

  • 1. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study.
    Melzacka M; Danek L; Adamus A
    Pol J Pharmacol Pharm; 1987; 39(4):379-86. PubMed ID: 3449809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prolonged administration of imipramine on its hepatic metabolism in rats.
    Daniel W; Melzacka M
    Pol J Pharmacol Pharm; 1987; 39(2):135-41. PubMed ID: 3432159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat.
    Besret L; Debruyne D; Rioux P; Bonvalot T; Moulin M; Zarifian E; Baron JC
    J Pharm Sci; 1996 Mar; 85(3):291-5. PubMed ID: 8699331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI; Suckow RF; Cooper TB
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in hepatic microsomal drug-metabolizing enzymes.
    Danek L; Nocoń H; Tarnawska A; Melzacka M
    Pol J Pharmacol Pharm; 1988; 40(4):351-6. PubMed ID: 3222176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
    Pentel PR; Keyler DE; Brunn GJ; Milavetz JM; Gilbertson DG; Matta SG; Pond SM
    Drug Metab Dispos; 1991; 19(1):24-8. PubMed ID: 1673407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2003; 55(6):993-9. PubMed ID: 14730094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL; Simpkins JW; Stout SA
    Psychopharmacology (Berl); 1984; 84(2):225-30. PubMed ID: 6438681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B; Holle L
    Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain.
    Daniel W; Melzacka M
    Biochem Pharmacol; 1986 Oct; 35(19):3249-53. PubMed ID: 2876708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of proadifen, an inhibitor of the metabolism of drugs, on the action of imipramine and desipramine in rats.
    Maj J; Daniel W; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(6):559-67. PubMed ID: 7347808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.